Tokuhisa Motohiko, Ichikawa Yasushi, Kosaka Nobuyoshi, Ochiya Takahiro, Yashiro Masakazu, Hirakawa Kosei, Kosaka Takashi, Makino Hirochika, Akiyama Hirotoshi, Kunisaki Chikara, Endo Itaru
Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Department of Clinical Oncology, Yokohama City University Graduate school of Medicine, Yokohama, Japan.
PLoS One. 2015 Jul 24;10(7):e0130472. doi: 10.1371/journal.pone.0130472. eCollection 2015.
Peritoneal metastasis is the most frequent type of recurrence in patients with gastric cancer (GC) and is associated with poor prognosis. Peritoneal lavage cytology, used to evaluate the risk of peritoneal metastasis, has low sensitivity. Here, we assessed the diagnostic potential of exosomal miRNA profiles in peritoneal fluid for the prediction of peritoneal dissemination in GC. Total RNA was extracted from exosomes isolated from six gastric malignant ascites (MA) samples, 24 peritoneal lavage fluid (PLF) samples, and culture supernatants (CM) of two human gastric carcinoma cell lines that differ in their potential for peritoneal metastasis. Expression of exosomal miRNAs was evaluated with Agilent Human miRNA microarrays and quantitative reverse transcription polymerase chain reaction (qRT-PCR). The microarray analysis indicated a low variability in the number and signal intensity of miRNAs detected among the samples. In the six MA fluids, miR-21 showed the highest signal intensity. We identified five miRNAs (miR-1225-5p, miR-320c, miR-1202, miR-1207-5p, and miR-4270) with high expression in MA samples, the PLF of serosa-invasive GC, and the CM of a highly metastatic GC cell line; these candidate miRNA species appear to be related to peritoneal dissemination. Differential expression of miR-21, miR-320c, and miR-1225-5p was validated in the PLF of serosa-invasive and non-invasive GC by qRT-PCR and miR-21 and miR-1225-5p were confirmed to be associated with serosal invasion in GC. PLF can be used to profile the expression of exosomal miRNAs. Our findings suggest that miR-21 and miR-1225-5p may serve as biomarkers of peritoneal recurrence after curative GC resection, thus providing a novel approach to early diagnosis of peritoneal dissemination of GC.
腹膜转移是胃癌(GC)患者最常见的复发类型,且与预后不良相关。用于评估腹膜转移风险的腹腔灌洗细胞学检查敏感性较低。在此,我们评估了腹腔积液中外泌体微小RNA(miRNA)谱对预测GC腹膜播散的诊断潜力。从六个胃恶性腹水(MA)样本、24个腹腔灌洗液(PLF)样本以及两种腹膜转移潜能不同的人胃癌细胞系的培养上清液(CM)中分离出的外泌体中提取总RNA。使用安捷伦人类miRNA微阵列和定量逆转录聚合酶链反应(qRT-PCR)评估外泌体miRNA的表达。微阵列分析表明,样本中检测到的miRNA数量和信号强度变化较小。在六个MA样本中,miR-21的信号强度最高。我们鉴定出五个在MA样本、浆膜浸润性GC的PLF以及高转移性GC细胞系的CM中高表达的miRNA(miR-1225-5p、miR-320c、miR-1202、miR-1207-5p和miR-4270);这些候选miRNA种类似乎与腹膜播散有关。通过qRT-PCR在浆膜浸润性和非浸润性GC的PLF中验证了miR-21、miR-320c和miR-1225-5p的差异表达,并且证实miR-21和miR-1225-5p与GC的浆膜侵犯有关。PLF可用于分析外泌体miRNA的表达。我们的研究结果表明,miR-21和miR-1225-5p可能作为GC根治性切除术后腹膜复发的生物标志物,从而为GC腹膜播散的早期诊断提供一种新方法。